Delivery Order SPE2DB20D3505-SPE2DB25FV0R7
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,991.50 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 25, 2025, with ultimate completion scheduled for August 26, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract specifies performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the nation's leading pharmaceutical distributor, for the supply of Boostrix TDAP vaccine in 0.5ml syringes. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,318.30 with an ultimate completion date of September 22, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, valued at $7,077.10 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 20, 2025, and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $3,696.56, for Boostrix TDAP vaccine in 0.5mL syringe format. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 18, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) valued at $1,044.92 under a firm fixed price contract with an ultimate completion date of August 28, 2025. This non-set-aside award represents a single delivery order positioned as a child contract, leveraging the company's extensive pharmaceutical supply capabilities and established federal procurement relationships. The vaccine delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 0.5ML Boostrix TDAP vaccine syringes with a contract value of $1,330.50 on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 11, 2025, with a ceiling value of $22,083.83. This firm fixed-price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The contract is unclassified as a set-aside and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $14,722.52. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $7,836.90 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringe format. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...